Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PNRC
(proline-rich nuclear receptor coregulatory protein) was primarily identified as a coactivator of nuclear receptors (NRs) by our laboratory, which enhances NR-mediated transcription by
RNA polymerase II
. Recent study has shown that
PNRC
also stimulates
RNA polymerase III
-dependent transcription through interaction with the subunit RPC39 of
RNA polymerase III
. Here, we report that
PNRC
accumulates in the nucleolus and its depletion by small interfering RNA (siRNA) impairs pre-rRNA transcription by
RNA polymerase I
. We identified the sequence at position 94-101 ((94)PKKRRKKK(101)) of
PNRC
as its nucleolar localization sequence (NoLS). Fusion of this sequence to GFP directed GFP to the nucleolus. Characterization of the NoLS revealed that the stretches of six successive basic residues are sufficient to function as a NoLS. Through co-immunoprecipitation assay, we demonstrated that the NoLS is necessary and sufficient to mediate the association of
PNRC
with B23/nucleophosmin. Moreover, B23 depletion by siRNA disrupted the accumulation of
PNRC
in the nucleolus. Together, our study indicates that
PNRC
is a novel nucleolar protein that might be involved in regulation of pre-rRNA synthesis, and it localizes to the nucleolus by interaction with B23 via its NoLS. Our study also suggests that the stretches of six successive basic residues (lysine and/or arginine) could function as NoLS.
...
PMID:PNRC accumulates in the nucleolus by interaction with B23/nucleophosmin via its nucleolar localization sequence. 2088 65